What changed
$VEEV — WATCHLIST 📊
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
🎯 Q1 FY26 | Rev $1B | EPS $2.24 vs $2.14 🟢
💡 Consensus expects sustained >20% revenue growth and margin expansion to justify current multiples. Our variant view: growth is decelerating into the mid-teens, and the EPS beat was driven by incremental margin improvement that may not be repeatable.
📉 Reward/Risk: 1.63:1
🏢 Business Quality: 8/10 - Dominant SaaS platform for life sciences, high switching costs, strong cash generation, but growth rates are maturing.
📊 Valuation: rich - P/S ~29x TTM revenue (based on provided $100B market cap; note: data may be inconsistent with actual share count), vs. historical 10–20x.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/VEEV0619
Why it matters
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.